The Fda announced in the Federal Register on Wednesday that the agency is seeking public comment on the “abuse potential, actual abuse [and] medical usefulness” of several substances, including marijuana. This comes as the World Health Organization’s Expert Committee on Drug Dependence (Ecdd) prepares to discuss the international scheduling of cannabis at a meeting in Geneva, Switzerland, this November. The request for comment is part of the U.S. preparation for a response to the Who’s eventual findings. Currently, the plant is classified in the United States as Schedule...